Delivery Order SPE2DB22D1103-SPE2DB25FH3G7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order valued at $4,455.71 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.06 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1/10 tablets (28-count packages) with a firm fixed price and no set-aside designation. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,733.20 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers the supply of this specific pharmaceutical product to support federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,544.36 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price delivery order is a competitive award with no set-aside designation and represents a child contract under AmerisourceBergen's broader relationship with federal medical procurement. The product will be performed at the vendor's...
- The Defense Logistics Agency awarded a $1,171.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count units. This is a non-set-aside contract with a completion date of June 3, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,575.17 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,841.98 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) with a completion date of June 9, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3G7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,604.53 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s on September 25, 2025, with completion anticipated by September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply requirement fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is part of AmerisourceBergen's broader engagement with DLA's Medical Supply Chain, through which the company serves federal healthcare systems supporting military and veteran medical needs. This delivery order derives from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a diverse portfolio of pharmaceuticals and medical commodities to support military healthcare programs worldwide, including products serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across various therapeutic domains demonstrates its capability to meet federal pharmaceutical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/25/25 |